In pancreatic cancer, Matsumoto et al (2002) recently demonstrated that neither mutation of K-ras or PTEN is associated with activation of AKT, though HER-2/neu signalling was not investigated. Here, ERBB2 is linked to familial pancreatic carcinoma.